ATC level 3
J06BImmunoglobulin therapy
- Molecules
- 12
- Subgroups
- 3
ATC J06B (Immunoglobulin therapy) is a level 3 group in the anatomical therapeutic chemical classification. The catalogue lists 12 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under J06B.
- AnsuvimabOrphanZaire Ebolavirus Glycoprotein-directed Antibody1 presentation1 brandJ06BD04
- BezlotoxumabBiologic1 presentation1 brandJ06BB21
- ClesrovimabBiologicRespiratory Syncytial Virus Anti-F Protein Monoclonal Antibody1 presentation1 brandJ06BD10
- Human hepatitis b immunoglobulin1 brandJ06BB04
- Human hepatitis b virus immune globulinBiologicHuman Immunoglobulin3 presentations3 brandsJ06BB04
- Human immunoglobulin gBiologicHuman Immunoglobulin G81 presentations19 brandsJ06BA02
- Human normal immunoglobulin6 brandsJ06BA01
- NirsevimabBiologicRespiratory Syncytial Virus Anti-F Protein Monoclonal Antibody2 presentations2 brandsJ06BD08
- ObiltoxaximabOrphanAnthrax Protective Antigen-directed Antibody1 presentation1 brandJ06BB22
- Palivizumab1 brandJ06BB16
- RaxibacumabOrphanAnthrax Protective Antigen-directed Antibody1 presentationJ06BB18
- Sipavibart1 brandJ06BD09
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.